DT MedTech Secures CE Marking and begins Active Distribution of Hintermann Series H3 Lower Extremity Medical Devices

MEDIA CONTACT:
Jeannie Sarda
DT MedTech, LLC
877-494-2252
info@dtmedtech.com

FOR IMMEDIATE RELEASE:

DT MedTech Assumes Production and Distribution of Hintermann Series™ Lower Extremity Medical Devices

April 29, 2016 (Baltimore, MD) – DT MedTech, LLC (DTMT) announced today that on May 1, 2016, it will officially take over all production, sales, and worldwide distribution of the Hintermann Series™ lower extremity device product line. Developed by prominent surgeon, Prof. Beat Hintermann, the line includes: (1) Hintermann Series H3™ 3-piece Total Ankle Replacement prosthesis, including the Standard and Revision models (formerly known as the HINTEGRA Total Ankle Replacement prosthesis); (2) the Kalix II™, a subtalar arthroereisis implant to treat flatfoot deformities; and (3) instrumentation to support the implantable devices.

Current manufacturers who have been producing the Hintermann Series products for the past 10 years, will continue to manufacture all products for DTMT, and Healthlink Europe has been contracted to handle the majority of logistics outside of the United States, beginning immediately.

David Reicher, president and chief executive officer of DTMT, stated, “Everyone at DT MedTech is excited to take ownership of this superior, clinically-proven line of the Hintermann Series lower extremity medical devices, and eager to start producing and distributing these life-altering products worldwide.”

“We especially want to thank everyone involved for all of their hard work in making the transition as seamless as possible. We understand there may be issues as we embark on this journey and ask that any questions our customers may have, be directed to Jeannie Sarda at info@dtmedtech.com, or by calling her at 410-494-4994, ext. 250, in the US.”

About DT MedTech, LLC

DT MedTech, LLC maintains offices in Baltimore, Maryland; Salt Lake City, Utah; Saint-Louis, France; and Liestal, Switzerland, and is a stand alone limited liability company owned by Data Trace Partners III, LLC and ROBEAMA GmbH. As a member of the Data Trace family of businesses, leaders in scientific and medical publishing, marketing, medical malpractice insurance, and information services for more than 29 years, DTMT is well-positioned to provide innovative surgical solutions for lower extremity surgeons with state-of-the-art devices designed to seek to ensure the highest quality prosthesis resulting in better patient outcomes. The Hintermann Series H3 Total Ankle Replacement, H3 Revision, and H3 Sensitive prosthesis have been time-tested for over 15 years with consistent, successful results.




Original Text by Clifford R. Wheeless, III, MD.

Last updated by Data Trace Staff on Thursday, August 18, 2016 5:48 am